Vertex says another type 1 diabetes patient is insulin-free in updated data out of EASD
Vertex Pharmaceuticals’ islet cell therapy has produced more promising early data in type 1 diabetes patients, with a third reaching independence from insulin and all …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
